Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Celgene
- 入组人数
- 1,494
- 试验地点
- 165
- 主要终点
- Identify and summarize patterns in therapeutic regimens and patient outcomes
研究概览
简要总结
The purpose of the Connect™ Chronic Lymphocytic Leukemia (CLL) Disease Registry is to explore the history and real world management of patients diagnosed with CLL, provide insight into the management of CLL, and evaluate the effectiveness of first, second and subsequent therapeutic strategies employed in both the community and academic settings.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis with CLL
- •Clinical decision made to initiate first-line therapy, second-line therapy or subsequent line of therapy prior to enrollment into the ConnectTM CLL registry, but within 2 months of enrollment
- •Age≥18 years
- •Willing and able to provide signed informed consent
- •Willing and able to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel
排除标准
- •Participation in a clinical study in which study treatment is blinded
- •Patient condition is considered terminal (i.e.<6 months to live)
结局指标
主要结局
Identify and summarize patterns in therapeutic regimens and patient outcomes
时间窗: up to 8 years
The primary objective is to 1) describe practice patterns of first line therapy regimens and subsequent therapeutic strategies in patients initiated on therapy for CLL, as well as initiated on second line and subsequent therapies, in the community and academic setting (2) Provide insight into therapeutic regimens and therapy sequence in clinical practice as they relate to clinical outcomes in patients initiated on first-line, second-line or subsequent therapies for CLL.
次要结局
- Health Related Quality of Life Measures Related to Therapeutic Regimens(up to 8 years)
- Summarize Effectiveness of Treatment Regimens(up to 8 years)